Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SCHEDULE – M – Revised

The Future of Schedule M (Revised) GMP Guidelines in India

Posted on December 28, 2024 By digi

The Future of Schedule M (Revised) GMP Guidelines in India Exploring the Evolution and Future Prospects of Schedule M (Revised) GMP Guidelines in India Introduction to Schedule M (Revised) Schedule M (Revised), under the Drugs and Cosmetics Act, 1940, has been a cornerstone for ensuring Good Manufacturing Practices (GMP) in India’s pharmaceutical industry. It provides…

Read More “The Future of Schedule M (Revised) GMP Guidelines in India” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Contributes to the Global Pharmaceutical Market

Posted on December 29, 2024 By digi

How Schedule M (Revised) GMP Contributes to the Global Pharmaceutical Market The Role of Schedule M (Revised) GMP in Strengthening India’s Position in the Global Pharmaceutical Market Introduction to Schedule M (Revised) and Its Global Significance India’s pharmaceutical industry is a global powerhouse, recognized for its affordable and high-quality generic drugs. The foundation of this…

Read More “How Schedule M (Revised) GMP Contributes to the Global Pharmaceutical Market” »

SCHEDULE - M - Revised

How to Integrate Schedule M (Revised) GMP with Other National Regulatory Guidelines

Posted on December 30, 2024 By digi

How to Integrate Schedule M (Revised) GMP with Other National Regulatory Guidelines Integrating Schedule M (Revised) GMP with National and International Regulatory Frameworks Introduction to Regulatory Integration in Pharma The pharmaceutical industry operates in a highly regulated environment, with manufacturers required to comply with various national and international guidelines. In India, Schedule M (Revised) under…

Read More “How to Integrate Schedule M (Revised) GMP with Other National Regulatory Guidelines” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs

Posted on December 31, 2024 By digi

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs Preventing Counterfeit Drugs with Schedule M (Revised) GMP Guidelines Introduction to Counterfeit Drugs and Their Risks Counterfeit drugs pose a serious threat to public health and the pharmaceutical industry. These illegal products, which mimic legitimate medicines, often lack active ingredients, contain harmful substances,…

Read More “How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs” »

SCHEDULE - M - Revised

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing

Posted on December 31, 2024 By digi

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing Leveraging Technology to Comply with Schedule M (Revised) GMP in Pharmaceutical Manufacturing Introduction to Technology in Pharmaceutical GMP Pharmaceutical manufacturing has evolved significantly with advancements in technology. As regulations become more stringent, technology plays an indispensable role in ensuring compliance with Good Manufacturing…

Read More “Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

How to Overcome Schedule M (Revised) GMP Challenges in Pharma Operations

Posted on January 1, 2025 By digi

How to Overcome Schedule M (Revised) GMP Challenges in Pharma Operations Strategies to Address Schedule M (Revised) GMP Challenges in Pharmaceutical Operations Introduction to Schedule M (Revised) GMP Challenges The pharmaceutical industry in India relies heavily on Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, to maintain the quality, safety, and efficacy of…

Read More “How to Overcome Schedule M (Revised) GMP Challenges in Pharma Operations” »

SCHEDULE - M - Revised

The Role of Schedule M (Revised) GMP in the Manufacture of Orphan Drugs

Posted on January 2, 2025 By digi

The Role of Schedule M (Revised) GMP in the Manufacture of Orphan Drugs Ensuring Quality and Compliance in Orphan Drug Manufacturing with Schedule M (Revised) GMP Introduction to Orphan Drugs Orphan drugs are pharmaceutical products developed specifically to treat rare diseases or conditions, which affect a small percentage of the population. While these drugs play…

Read More “The Role of Schedule M (Revised) GMP in the Manufacture of Orphan Drugs” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Supports India’s Pharmaceutical Export Growth

Posted on January 2, 2025 By digi

How Schedule M (Revised) GMP Supports India’s Pharmaceutical Export Growth The Role of Schedule M (Revised) GMP in Enhancing India’s Pharmaceutical Exports Introduction to India’s Pharmaceutical Export Landscape India has established itself as a global leader in pharmaceutical exports, supplying high-quality medicines to over 200 countries, including highly regulated markets like the US, EU, and…

Read More “How Schedule M (Revised) GMP Supports India’s Pharmaceutical Export Growth” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Enhances the Quality of Pharmaceutical Products

Posted on January 3, 2025 By digi

How Schedule M (Revised) GMP Enhances the Quality of Pharmaceutical Products Improving Pharmaceutical Product Quality with Schedule M (Revised) GMP Guidelines Introduction to Pharmaceutical Quality Standards In the pharmaceutical industry, product quality is non-negotiable. Medications must be safe, effective, and consistent to protect patient health. In India, Schedule M (Revised) under the Drugs and Cosmetics…

Read More “How Schedule M (Revised) GMP Enhances the Quality of Pharmaceutical Products” »

SCHEDULE - M - Revised

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals

Posted on January 4, 2025 By digi

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals Ensuring Compliance with Schedule M (Revised) GMP in Biopharmaceutical Manufacturing Introduction to Biopharmaceuticals and GMP Compliance Biopharmaceuticals represent a rapidly growing segment of the pharmaceutical industry, offering innovative therapies for complex diseases such as cancer, autoimmune disorders, and genetic conditions. However, their production involves…

Read More “Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 3 4 5 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme